NGL Fine Chem's Q1 FY 2026-27 Quarterly Results
- 13 Aug 2026
Result Summary
- NGL Fine Chem Ltd reported a 3.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 32.6%.
- Its expenses for the quarter were down by 8.8% QoQ and up 23.7% YoY.
- The net profit increased 36.4% QoQ and increased 99.1% YoY.
- The earnings per share (EPS) of NGL Fine Chem Ltd stood at 29.78 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 146.59 | 151.69 | 110.54 | -3.4% | 32.6% |
Total Expenses | 122.12 | 133.88 | 98.70 | -8.8% | 23.7% |
Profit Before Tax | 24.48 | 17.81 | 11.84 | 37.5% | 106.8% |
Tax | 6.08 | 4.33 | 2.60 | 40.4% | 133.8% |
Profit After Tax | 18.40 | 13.49 | 9.24 | 36.4% | 99.1% |
Earnings Per Share | 29.78 | 21.83 | 14.96 | 36.4% | 99.1% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
NGL Fine Chem Ltd is a company operating in the pharmaceutical industry, primarily engaged in the production of veterinary pharmaceuticals. The company specializes in manufacturing and supplying active pharmaceutical ingredients (APIs) used in the treatment of animal health. As a key player in the veterinary medicines sector, NGL Fine Chem Ltd’s portfolio includes a range of products designed to support the health and productivity of livestock. Recent major developments surrounding the company are not available from the data provided, but it continues to be recognized for its contributions to veterinary medicine.
Revenue
In the first quarter of FY27, NGL Fine Chem Ltd reported a total income of ₹146.59 crores. This represents a decrease of 3.4% when compared to the previous quarter (Q4FY26), where the total income was ₹151.69 crores. However, on a year-over-year basis, there was a substantial increase of 32.6% from Q1FY26, which saw total income at ₹110.54 crores. This indicates significant growth in revenue over the past year, despite a slight decline from the previous quarter.
Profitability
The company’s profitability metrics for Q1FY27 show a profit before tax of ₹24.48 crores, reflecting a quarter-over-quarter increase of 37.5% from ₹17.81 crores in Q4FY26. Year-over-year, the profit before tax has more than doubled, showing an increase of 106.8% from ₹11.84 crores in Q1FY26. The profit after tax for Q1FY27 stood at ₹18.40 crores, which is an increase of 36.4% from the previous quarter’s ₹13.49 crores and a 99.1% increase year-over-year from Q1FY26’s ₹9.24 crores. The earnings per share for this quarter was ₹29.78, maintaining the same percentage increase as the profit after tax on both QoQ and YoY bases.
Operating Metrics
Total expenses for NGL Fine Chem Ltd in Q1FY27 were ₹122.12 crores, which represents an 8.8% decrease from the previous quarter’s expenses of ₹133.88 crores. Year-over-year, total expenses increased by 23.7% compared to Q1FY26’s ₹98.70 crores. The tax expense for Q1FY27 was ₹6.08 crores, up by 40.4% from ₹4.33 crores in Q4FY26, and it increased by 133.8% compared to ₹2.60 crores in Q1FY26. These figures reflect significant financial changes, with an emphasis on cost management and tax implications as part of the company’s operational dynamics.
FAQs
NGL Fine Chem Ltd announced its Q1 FY 2026-27 results on 13 August, 2026.
NGL Fine Chem Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of NGL Fine Chem Ltd Q1 FY 2026-27 results include:
- Revenue: ₹146.59 crore
- Net Profit: ₹18.40 crore
- EBITDA: ₹30.72 crore
- Year-over-Year Growth: 32.6%
- Quarter-over-Quarter Growth: -3.4%
NGL Fine Chem Ltd reported a net profit of ₹18.40 crore in Q1 FY 2026-27, reflecting a 99.1% year-over-year growth.
NGL Fine Chem Ltd posted a revenue of ₹146.59 crore in Q1 FY 2026-27.